TMZ1 Nov 2012 07:42
Toumaz Limited
Major hospital pilot deployment of Toumaz's wireless plaster to monitor vital signs underway
Toumaz Limited (AIM: TMZ, 'Toumaz', or the 'Group'), a pioneer in low cost, ultra-low power wireless technology, has started to pilot its digital vital signs plaster, SensiumVitals, in a major US hospital.
The SensiumVitals monitor is a disposable, ultra-thin plaster which continuously monitors the patient's heart rate, respiratory rate and temperature whilst in hospital. This significantly increases patient surveillance compared to current practice, which involves manual measurement of vital signs every six to eight hours.
The device, which also has an alert capability, enables patients to be fully mobile whilst being monitored, so helping to promote patient morale and recovery. SensiumVitals is targeted at the general wards of hospitals which account for the vast majority of hospital beds, unlike traditional, bulky, wired monitoring products which are usually only found in hospital intensive care units.
SensiumVitals also provides hospitals with significant cost-savings as continuous monitoring can reduce the number of patients who have to be admitted or readmitted to costly intensive care, as any deterioration in condition can be alerted and dealt with immediately.
In the US alone, wireless vital signs monitoring devices are forecast to reduce healthcare costs by around $200 billion over the next 25 years. (Center for Technology and Aging Report, May 2010).
The pilot is being carried out at St. John's Health Centre in Santa Monica, California, by Toumaz US, the Group's US joint venture with Dr Patrick Soon-Shiong's company, NantWorks.